- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Eli Lilly and Co.
Lilly warehouse thieves had security report, lawsuit says
April 2, 2013
Associated PressA federal lawsuit contends that thieves who broke into an Eli Lilly and Co. warehouse in Connecticut three years ago and stole
more than $60 million worth of drugs obtained a copy of a report that revealed weaknesses in the building's security system.
MoreLilly to spend $180M doubling size of Indy plant
April 2, 2013
The new investment will bring the plant's total price tag to $320 million as the pharmaceutical giant seeks to increase production
of insulin and related products.
MoreJ&J wins OK for first in new class of diabetes drugs
March 31, 2013
Bloomberg NewsJohnson & Johnson, the world’s largest seller of health-care products, won approval for the first in a new family
of diabetes drugs, giving them the edge against rivals including Eli Lilly and Co. that are developing similar medicines.
MoreLilly, Boehringer submit diabetes drug to FDA
March 25, 2013
Associated PressEli Lilly and Co. said Monday that it has submitted a new type 2 diabetes treatment it is developing with German drugmaker
Boehringer Ingelheim to the Food and Drug Administration.
MoreBonuses drive up compensation for Lilly's top brass
March 25, 2013
J.K. WallEli Lilly and Co. granted larger bonuses to its top five executives early this year, which boosted their 2012 compensation
anywhere from 3 percent to 8 percent.
MoreCourt may decide if drugmakers can pay to delay generics
March 25, 2013
Associated PressFederal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors
to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for
years, steep price declines.
MoreProfits at center of biosimilars debate
March 18, 2013
J.K. WallHouse Bill 1315, which is scheduled for a Senate floor hearing on Monday, would require pharmacists to check with a patient’s
physician before automatically substituting a generic version of a biotech drug for a brand-name version.
MoreFDA probe of diabetes medications hurts drugmakers' stock
March 15, 2013
Bloomberg News, Associated PressShares of several pharmaceutical companies that make diabetes medicines, including Eli Lilly, fell after U.S. regulators warned
they are looking into potential risks of drugs in two classes of diabetes treatments.
MoreDrugmakers, Interpol ramp up fight against fakes
March 12, 2013
Associated PressMore than two dozen of the world's largest pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., have
agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs.
MoreOverseas tax savings for U.S. drugmakers under threat
March 11, 2013
Bloomberg NewsEli Lilly and Co. and five other big drugmakers avoided paying $7 billion in U.S. taxes last year by shifting their profits
overseas. The strategy has drawn the ire of some legislators.
MoreLilly sues Genentech to invalidate Erbitux-related patents
March 2, 2013
Bloomberg NewsEli Lilly and Co. has sued Roche Holding AG’s Genentech unit, asking a court to invalidate patents used to make treatments
for cancer and autoimmune diseases.
MoreTestosterone for diabetes may be new market for Lilly, others
February 25, 2013
Bloomberg NewsResearchers suspect the sex hormone known to increase libido and musculature could also play a role in preventing a form of
diabetes that tends to strike later in life and afflicts more than 330 million people worldwide.
MoreLilly to expand partnership with diagnostic firm
February 14, 2013
IBJ Staff and Associated PressDiagnostic products maker Qiagen NV said Wednesday that it will work with Eli Lilly and Co. to develop new tests that could
identify patients who could be helped by Lilly's drugs.
MoreLilly halts late-stage testing of rheumatoid arthritis drug
February 7, 2013
Bloomberg NewsEli Lilly said it is halting testing of experimental drug tabalumab because the studies show the medicine is not effective.
The company said it expects to take a $50 million charge in the first quarter related to the research expenses from the drug.
MoreLilly aims to submit five new drugs for approval
February 4, 2013
J.K. WallWith Eli Lilly and Co. set to see patents expire on its best-selling drug at year’s end, it is in the company’s
interest to say its pipeline is about to produce new drugs. But the Indianapolis drugmaker may be in a position to submit
five new drugs for regulatory approval this year.
MoreLilly's profit drops 4 percent, but beats analysts' estimates
January 29, 2013
J.K. WallPrice increases and sales gains helped Eli Lilly and Co. offset declining revenue from its former blockbuster Zyprexa in the
fourth quarter, allowing the company to beat analysts' expectations and raise its 2013 profit forecast.
MoreEli Lilly and Co.'s rebound bolsters endowment
January 19, 2013
Dan HumanThe value of Lilly Endowment Inc.’s principal holding—Eli Lilly and Co. stock—has increased nearly $2 billion
over the past two years, bolstering the private foundation’s philanthropic firepower after a decade of declining or
stagnant assets.
MoreLilly drug chosen for Alzheimer's prevention study
January 18, 2013
Associated PressResearchers have chosen an experimental drug by Eli Lilly and Co. for a large federally funded study testing whether it's
possible to prevent Alzheimer's disease in older people at high risk of developing it.
MoreLilly's Amyvid receives European approval
January 16, 2013
Associated PressEuropean regulators approved the use of an imaging agent from Eli Lilly and Co., which can help doctors diagnose Alzheimer's
disease.
MoreLilly competitor gets backing on diabetes drug
January 10, 2013
Bloomberg NewsJohnson & Johnson, the world’s largest seller of health-care products, won the backing of U.S. advisers for a diabetes pill
the company is seeking to make the first in a new family of drugs for managing blood sugar.
MoreLilly settles with four sisters in DES cancer case
January 9, 2013
Associated PressFour sisters who claimed their breast cancer was caused by a drug their mother took during pregnancy in the 1950s reached
a settlement Wednesday with Eli Lilly and Co. in the first of scores of similar claims around the country to go to trial.
MoreDrug sold by Lilly caused cancer, women claim at Boston trial
January 8, 2013
Associated PressIn opening statements Tuesday, a lawyer for Indianapolis-based Lilly told the jury there is no evidence the synthetic estrogen
known as DES causes breast cancer in the daughters of women who took it.
MoreBig drug deals expected to return in 2013
January 7, 2013
Bloomberg NewsPharmaceutical companies including Pfizer Inc., Bristol-Myers Squibb Co. and Eli Lilly and Co. could be ready to start making
major acquisitions again.
MoreLilly's 2013 profit forecast tops expectations
January 4, 2013
Associated PressEli Lilly and Co. forecasts its 2013 earnings will grow more than Wall Street expects even though the drugmaker will lose
U.S. patent protection for two more key products in the new year.
MoreTrial set to begin over pregnancy drug sold by Lilly
January 3, 2013
Associated PressFour sisters diagnosed with breast cancer are suing Eli Lilly and Co., a former maker of DES, or diethylstilbestrol, a drug
taken by their mother in the 1950s when she was pregnant. It could be the first of scores of such trials over the drug.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Saw the Indy Men's Chorus "Music of Gilbert & Sullivan" at the Indiana Historical Society on Sunday evening.
Temporary workers are not "tools" they are people and companies that keep large amounts of temp staff are cheating.
I miss having them around. I hope one of their stores is in the general Meridian/86th Street area. I will make good use of it.
The Fringe! Plus, the simple fact that there are so many local faves in such close proximity to each other.
I remenber, watching the toll road, being built, through South Bend, when I was 10 years old. I believe, back then that it was estimated, that the toll road, would be paid for in 20 years and then it would be free. I am now 71, what happened? Since the power is in the people, by that, I mean that, we the people are in total control of everything. I, suggest that no one ever use the toll road again, let it go broke. We the people can control the price of everything, from groceries to gas, if we would just do it. If we don't pay the asking price, the sellers will lower the price and if we wait awhile, they will lower the price to what we accept as reasonable. I would like to know why a highway like interstate 94, is so well maintained, a much better highway, than the toll road, but has no tolls. I would also like to know why, a sitting governor, with a term limit, maximum of eight years, can lease, public property, for 75 years. Even though I have transponders in both of my trucks and will not be affected by the increase, I have been and will contine to avoid using the toll road. I make many trips from northern Indiana to Chicago, every year, and I prefer the better highway, I94!